The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
暂无分享,去创建一个
Stefan Grimm | Yasumasa Ishida | P. Leder | S. Grimm | F. Kuo | M. Kelliher | B. Stanger | Michelle A Kelliher | Y. Ishida | Philip Leder | Frank C. Kuo | Ben Z. Stanger
[1] S. Grimm,et al. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis , 1996, The Journal of cell biology.
[2] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .
[3] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[4] R. Flavell,et al. Distinct Roles in Lymphoid Organogenesis for Lymphotoxins α and β Revealed in Lymphotoxin β–Deficient Mice , 1997 .
[5] A. Chinnaiyan,et al. Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95 , 1996, Science.
[6] E. Chen,et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[7] D. Wallach,et al. MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.
[8] B. Seed,et al. RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis. , 1996, The EMBO journal.
[9] D. Goeddel,et al. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.
[10] E. Zandi,et al. The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.
[11] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[12] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[13] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[14] D. Goeddel,et al. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. , 1996, Immunity.
[15] Michael Karin,et al. Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.
[16] D. Goeddel,et al. A death-domain-containing receptor that mediates apoptosis , 1996, Nature.
[17] Mike Rothe,et al. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor , 1993, Cell.
[18] D. Goeddel,et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice , 1994, Nature.
[19] E M Schwarz,et al. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.
[20] D. Baltimore,et al. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. , 1988, Science.
[21] Stephen J. Elledge,et al. Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.
[22] Mike Rothe,et al. IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .
[23] Hong-Bing Shu,et al. TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.
[24] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[25] P. Leder,et al. RIP and FADD: two "death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[26] Vishva M. Dixit,et al. RAIDD is a new 'death' adaptor molecule , 1997, Nature.
[27] Scott F. Smith,et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. , 1994, Science.
[28] R. Bronson,et al. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.
[29] K. Bauer,et al. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB , 1996, Current Biology.
[30] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.
[31] D. Goeddel,et al. Identification and Characterization of an IκB Kinase , 1997, Cell.
[32] D. Baltimore,et al. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. , 1996, Immunity.
[33] P. Leder,et al. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death , 1995, Cell.
[34] T. Mak,et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.
[35] Matthias Mann,et al. IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .
[36] A. Baldwin,et al. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. , 1993, Genes & development.
[37] R. Zinkernagel,et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.
[38] B. Dérijard,et al. Transcription factor ATF2 regulation by the JNK signal transduction pathway , 1995, Science.
[39] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.
[40] P. Leder,et al. Tal‐1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. , 1996, The EMBO journal.
[41] C. Ware,et al. A lymphotoxin-beta-specific receptor. , 1994, Science.
[42] D. Goeddel,et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. , 1997, Immunity.
[43] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.